Hydroxyzinum Adamed

Hydroxyzine Hydrochloride, the active ingredient in Hydroxyzinum Adamed, is a first‑generation antihistamine presented as an oral tablet for oral use. It treats allergic skin conditions, anxiety, and provides sedation before or after surgery in adult patients.

GNH USA supplies Hydroxyzinum Adamed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxyzinum Adamed, a first‑generation antihistamine, acts on peripheral H1 receptors to relieve allergic and related conditions.

Urticaria and pruritus: reduces itching and rash associated with allergic skin reactions. Anxiety and tension: alleviates symptoms of anxiety in adult patients. Surgical sedation: provides pre‑operative or post‑operative calming effect. Nausea and vomiting: helps control nausea in various clinical settings.

Hydroxyzinum Adamed may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness - Dry mouth - Blurred vision - Constipation - Headache - Dizziness

Serious or Rare Side Effects: - Cardiac arrhythmia - Severe hypotension - Anaphylactic reaction - Seizures - Hepatic dysfunction - QT interval prolongation

Before prescribing Hydroxyzinum Adamed, consider the following precautions to ensure safe use.

Pregnancy: Category B – use only if potential benefit justifies the potential risk to the fetus. Elderly patients: increased sensitivity to sedative and anticholinergic effects; monitor closely. Renal impairment: may require dose adjustment; assess renal function prior to use. Concomitant CNS depressants: risk of enhanced sedation and respiratory depression; avoid or use with caution. Alcohol consumption: may potentiate drowsiness and impair coordination; advise patients to limit intake. Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Hydroxyzinum Adamed can interact with other medicines; notable interactions are grouped by clinical significance.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypotension and serotonin syndrome. - CNS depressants (e.g., benzodiazepines, opioids): may cause profound sedation and respiratory depression. - Anticholinergic drugs: additive anticholinergic effects leading to confusion, urinary retention, or severe constipation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: hydroxyzine may enhance hypotensive effect. - Other anticholinergic agents: increased dry mouth, constipation, and blurred vision. - Alcohol: combined use can increase drowsiness and impair psychomotor performance.